Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API

Overview of attention for article published in Pharmaceutical Research, July 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#39 of 2,860)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

patent: 23 patents

Citations

dimensions_citation: 592 Dimensions

Readers on

mendeley: 407 Mendeley

So far, Altmetric has seen 23 patents that reference this research output.

Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API

About this Attention Score

Mentioned by

Citations

Readers on

Crystalline forms

Application US-10519176-B2

United States of America

Choline cocrystal of epalrestat

Application US-10464912-B2

United States of America

Cocrystal of emodin and processes for preparing the same

Application KR-20190110322-A

Republic of Korea

SUPERSATURATED COMPOSITIONS OF BENZIMIDAZOLE COMPOUNDS

Application US-20180344854-A1

United States of America

Crystallization Method and Bioavailability

Grant AU-2016219653-B2

Australia

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

Application EP-3295935-A3

European Patent Office

Salts of dasatinib in amorphous form

Grant US-9884857-B2

United States of America

PYRIMIDINES AS SODIUM CHANNEL BLOCKERS

Application EP-3255041-A1

European Patent Office

Pyrimidines as sodium channel blockers

Grant US-9656968-B2

United States of America

Crystalline forms

Grant US-9340565-B2

United States of America

Crystallization method and bioavailability

Grant US-9334296-B2

United States of America

Pyrimidines as sodium channel blockers

Grant US-9163008-B2

United States of America

NEW AGOMELATINE COCRYSTALS, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL…

Application EA-021386-B1

Eurasian Patent Organisation

Crystallization method and bioavailability

Grant US-8933057-B2

United States of America

Crystallization method and bioavailability

Grant US-8399023-B2

United States of America

PYRIMIDINES AS SODIUM CHANNEL BLOCKERS

Application WO-2013030665-A1

World Intellectual Property Organisation (WIPO)

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

Application EP-2459176-A4

European Patent Office

New agomelatine cocrystals comprising agomelatine or N-(2-(7-methoxy-1-naphthyl)ethyl)aceta…

Application FR-2976284-A1

France

NOVEL AGOMELATINE COCRYSTALS, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS…

Application WO-2012168665-A1

World Intellectual Property Organisation (WIPO)

New co-crystals of agomelatin

Application EP-2532647-A1

European Patent Office

Agomelatine-isonicotine eutectic crystal and compound and preparation method thereof

Application CN-102503886-A

China

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

Application EP-2459176-A2

European Patent Office

CRYSTALLINE FORMS OF ZOTEPINE HYDROCHLORIDE

Application WO-2009152347-A2

World Intellectual Property Organisation (WIPO)